Warren will describe his experience of LRRK2 research and drug development from the perspective of biopharma. The challenges, innovation, ups and downs will be presented from the early days of trying to figure out how to screen to the current clinical trials, which present their own hurdles.
Zoom registration link: https://stanford.zoom.us/meeting/register/tJMsf-6tqj8jHNZ2L-V6sOCciWE1KzsPPhjs
Thursday, November 17, 2022 - 13:00 ET
Warren Hirst (Biogen)